Analystreport

Quest Diagnostics Inc (NYSE: DGX) had its "buy" rating re-affirmed by analysts at Canaccord Genuity. They now have a $98.00 price target on the stock.

Quest Diagnostics Incorporated  (DGX) 
Last quest diagnostics incorporated earnings: 4/22 06:45 am Check Earnings Report
US:NYSE Investor Relations: ir.questdiagnostics.com